Latest News for: 128 bc

Edit

Non-Small Cell Lung Cancer Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by ...

GetNews 21 Mar 2025
Non-Small Cell Lung Cancer companies working in the treatment market are Merck Sharp & Dohme LLC, Qilu Pharmaceutical Co., Ltd., Merus N.V., Zymeworks BC ... Zenocutuzumab (MCLA-128) ... Zymeworks BC Inc.
  • 1
×